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Introduction {#sec001}
============

Alfalfa (*Medicago sativa* L.) is grown worldwide as a perennial high quality forage \[[@pone.0206641.ref001]\]. Alfalfa acreage in China has rapidly increased since the Chinese government initiated a program to promote the milk and alfalfa industries in 2012 \[[@pone.0206641.ref002]\]. The alfalfa acreage in 2015 was 4.7 million ha, which is planned to increase to more than 133 thousand ha in 2020 \[[@pone.0206641.ref003]\]. However, diseases limit alfalfa production \[[@pone.0206641.ref004]\]. Spring black stem and leaf spot caused by *Phoma medicaginis* var. *medicaginis* Malbr. & Roum commonly occurs in China \[[@pone.0206641.ref005]--[@pone.0206641.ref007]\], North America, Europe, and Africa \[[@pone.0206641.ref008]--[@pone.0206641.ref010]\], causing yield losses, decreasing forage quality \[[@pone.0206641.ref011]\], and affecting the health of livestock \[[@pone.0206641.ref012]\]. Previous studies showed that one variety, Aohan, bred in Inner Mongolia, China was highly resistant among the 70 alfalfa varieties tested from many counties including China, America, France, Australia, and Canada. \[[@pone.0206641.ref013],[@pone.0206641.ref014]\]. In two moderately resistant alfalfa genotypes, the leaves delayed spore germination, penetration, development of mycelium, pycnidia formation, and symptom development compared with leaves from susceptible alfalfa genotypes \[[@pone.0206641.ref011]\]. In recent studies of mechanisms of pathogenesis and disease-resistance, we showed that *P*. *medicaginis* decreased the transfer rate and capture efficiency of photosynthetic electrons, the amount of non-photochemical quenching (qN), and the carboxylation efficiency (CE) in alfalfa leaves \[[@pone.0206641.ref015]\]. Activity of the antioxidant enzymes, superoxide dismutase (SOD), catalase (CAT), and phenylalanine ammonia 1yase (PAL), increased earlier and to higher levels in resistant alfalfa varieties than in susceptible alfalfa varieties \[[@pone.0206641.ref013]\]. During infection of alfalfa with *P*. *medicaginis*, the fungitoxic phytoalexins, isoflavonoids such as medicarpin, sativan, formononetin 7-*O*-glucoside, and malonylated formononetin 7-*O*-glucoside increased in alfalfa leaves infected by *P*. *medicaginis* \[[@pone.0206641.ref016]--[@pone.0206641.ref018]\], and the activity of enzymes, and corresponding transcript level, involved in isoflavonoid biosynthesis including isoflavone reductase (IFR), PAL, and chalcone synthase (CHS) were also upregulated \[[@pone.0206641.ref016]\]. β-1, 3-glucanase was stimulated in the transcription of leaf tissues and cell suspensions of alfalfa \[[@pone.0206641.ref019]\]. Currently, little is known about the disease process and mechanism of pathogenesis for *P*. *medicaginis* on alfalfa, information which is important for the development of novel disease-control strategies and breeding resistant varieties. In this study, we analyzed the expressions of metabolites in *P*. *medicaginis*-inoculated and mock-inoculated alfalfa plant leaves using GC-MS. The up- or down-regulated metabolites were further analysed for their metabolism pathways and a complex metabolic network was developed. This complex metabolic network should extend our understanding of the mechanisms controlling *P*. *medicaginis* pathogenicity and alfalfa tolerance to this pathogen.

Materials and methods {#sec002}
=====================

Experimental design {#sec003}
-------------------

The strain of *P*. *medicaginis* var. *medicaginis*, LYZ00164 (Genbank accession KP207577) was isolated from alfalfa leaves collected from the field in Gansu province, China. The isolate was cultured on potato dextrose agar (PDA) media at 25 °C without light in an incubator for 3 weeks. A spore suspension was prepared with sterile distilled water, and the number of spores in the suspension was adjusted to 1--1.5×10^6^ spores⋅mL^−1^ with a hemocytometer \[[@pone.0206641.ref013]\]. Seeds of the susceptible alfalfa cultivar, Derby \[[@pone.0206641.ref015]\] were sown in 70 pots (6 seeds per pot) containing sterilized soil, and grown inside a greenhouse set at 25/15 °C (day/night) for two months. Thirty pots of seedlings were spray inoculated with a spore suspension of *P*. *medicaginis* using an atomizer, and the seedlings were covered with black plastic bags for 48 h to promote infection, then, grown without plastic bags in the greenhouse. Thirty additional pots of seedlings were sprayed with sterile water as healthy controls, and 10 pots of seedlings were retained for positive controls to observe symptoms and disease development. Symptoms were observed after inoculation. All plants were grown under the same conditions. Fully expanded leaves at the same development stage were harvested from the *P*. *medicaginis*- or water-inoculated plants at 2, 4, 6, 8, 12, 16, 20, 24, 26 and 28 days post inoculation (dpi). Three pots with six plants each were sampled at each sampling date. The harvested leaves were quickly frozen with liquid nitrogen and stored at -80°C until use.

Metabolite extraction, determination and identification {#sec004}
-------------------------------------------------------

Leaf samples (30 mg each, n = 3) were pulverised individually in mortars, and extracted with MeOH: H~2~O (3 × 0.5 mL, 4:1, v/v) and 75 μL ribitol (2 μg/μL^--1^, Shanghai Yuanye Biotechnology Co. LTD), which was used as an internal standard. MeOH soluble fractions were dried individually with nitrogen and each sample was gently mixed with 45 μL methoxyamine hydrochloride (20μg/μL^--1^, J&K Scientific Ltd.). The mixtures were incubated at 30 °C for 90 min followed by addition of 45 μL N,O-bis-(trimethylsilyl)-trifluoroacetamide (J&K Scientific Ltd.) to each sample and incubation at 70 °C for 30 min. Each sample was diluted with 90 μL hexane prior to injection as described previously \[[@pone.0206641.ref020]\].

An Agilent 7890A/5975C gas chromatograph-tandem mass spectrometer equipped with an autosampler 7693 (Agilent Technologies, America) was used for GC-MS detection. The detection conditions were as follows: ion source temperature at 230 °C, electron beam at 70 eV, Agilent 19191S-433 column with 30 m × 0.25 mm internal diameter and 0.25 μm film thickness, helium gas flow rate at 1 ml/min^-1^, splitless injection, and mass range at m/z 50--650. Constituents were determined under the following conditions: 80 to 240 °C at 6 °C per min, 240 to 280 °C at 10 °C per min, and 280°C for 10 min. The injection temperature was 270 °C. Three replication for GC-MS.

Compounds in leaves were tentatively identified with Automated Mass Spectral Deconvolution and Identification System (AMDIS), our in-house mass spectra library and the standard mass spectral database (National Institute of Standards and Technology, NIST, version 11.0). The signal/noise (S/N) of the tentatively identified compound was higher than 10 in the AMDIS and the compound shared greater than or equal to 80% similarity with the known compounds in the database, indicating that the metabolite identification was reliable \[[@pone.0206641.ref021],[@pone.0206641.ref022]\].

The identification of significantly different metabolites and their metabolic pathway construction {#sec005}
--------------------------------------------------------------------------------------------------

The amounts of tentatively identified compounds were normalised with the mean value of the internal standard. The normalised data were imported into SIMCA14.1 (Umetrics, Sweden) for further multi-variate statistical analysis, including principal component analysis (PCA) and orthogonal partial least-squares discriminant analysis (OPLS-DA). The Q^2^ value is a prediction error obtained through OPLS-DA analyses, and values greater than or equal to 0.5 are generally considered to have good predictive capability \[[@pone.0206641.ref023]\]. To validate OPLS-DA models, 200 random permutation tests were performed. The variable importance values (VIP) were obtained through OPLS-DA analyses. When the VIP value of a metabolite exceeded 1.0, this metabolite was considered to be a potentially regulated metabolite and its variables were further analysed using a two-way analysis of variance. When the *p* value was less than 0.05, this metabolite was considered to be a significantly regulated metabolite compared to the controls \[[@pone.0206641.ref024]\]. The significantly regulated metabolites were analysed using the MetaboAnalyst platform ([www.metaboanalyst.ca/](http://www.metaboanalyst.ca/)). The final metabolic network was established according to KEGG (<http://www.genome.jp/kegg/>) \[[@pone.0206641.ref025]\]. A heat map was drawn with Mev 4.8. Student's t test was used for comparison between groups at the same time point.

Results {#sec006}
=======

Symptoms and disease development {#sec007}
--------------------------------

Symptoms were observed as small black spots on inoculated leaf blades on the sixth day post inoculation ([Fig 1b](#pone.0206641.g001){ref-type="fig"}). Subsequently, lesions enlarged and coalesced ([Fig 1c and 1d](#pone.0206641.g001){ref-type="fig"}), while no such symptoms appeared on the leaf blades of controls ([Fig 1a](#pone.0206641.g001){ref-type="fig"}).

![Symptoms on alfalfa inoculated with *Phoma medicaginis* var. medicaginis.\
The symptoms observed at 8 d (b), 19 d (c) and 26 d (d) after inoculation, and without inoculation (controls) (a).](pone.0206641.g001){#pone.0206641.g001}

Metabolite profiles and metabolite response to pathogen stress {#sec008}
--------------------------------------------------------------

In total, 101 peaks were detected by GC-MS. From the peaks, 70 unique compounds were tentatively identified, including 23 carbohydrates and alcohols, 23 amino acids, 5 nitrogen-containing compounds, 10 organic acids, 5 lipids, 4 other compounds ([Table 1](#pone.0206641.t001){ref-type="table"}).

10.1371/journal.pone.0206641.t001

###### Identification of 70 metabolites from the control and inoculated leaves and the determination of 16 significantly regulated metabolites associated with *P*. *medicaginis* infection.

![](pone.0206641.t001){#pone.0206641.t001g}

  No.      Compound                                                                                    RT (min)   Characteristic fragment   Similarity   Inoculated group   Control group   *p*     VIP
  -------- ------------------------------------------------------------------------------------------- ---------- ------------------------- ------------ ------------------ --------------- ------- -------
  1        Glycine[^a^](#t001fn002){ref-type="table-fn"}[^b^](#t001fn003){ref-type="table-fn"}         10.452     102                       90           0.025±0.001        0.035±0.002     0.001   1.199
  2        Leucine[^a^](#t001fn002){ref-type="table-fn"}[^b^](#t001fn003){ref-type="table-fn"}         14.581     158                       95           0.270±0.016        0.362±0.020     0.001   1.214
  3        Isoleucine[^a^](#t001fn002){ref-type="table-fn"}[^b^](#t001fn003){ref-type="table-fn"}      15.124     158                       92           0.475±0.030        0.768±0.050     0.001   1.426
  4        Tyrosine[^a^](#t001fn002){ref-type="table-fn"}[^b^](#t001fn003){ref-type="table-fn"}        27.909     218                       96           0.119±0.011        0.228±0.013     0.001   1.577
  5        Methionine[^a^](#t001fn002){ref-type="table-fn"}[^b^](#t001fn003){ref-type="table-fn"}      20.166     176                       94           0.018±0.005        0.066±0.006     0.001   1.532
  6        5-oxoproline[^a^](#t001fn002){ref-type="table-fn"}[^b^](#t001fn003){ref-type="table-fn"}    20.233     156                       95           0.161±0.011        0.121±0.006     0.001   1.146
  7        Lysine[^a^](#t001fn002){ref-type="table-fn"}[^b^](#t001fn003){ref-type="table-fn"}          23.843     156                       96           0.070±0.004        0.093±0.006     0.001   1.088
  8        GABA[^a^](#t001fn002){ref-type="table-fn"}[^b^](#t001fn003){ref-type="table-fn"}            15.201     102                       90           0.149±0.016        0.398±0.055     0.001   1.204
  9        2-pyrrolidinone[^a^](#t001fn002){ref-type="table-fn"}                                       11.037     142                       92           0.029±0.003        0.050±0.002     0.001   1.592
  10       Myoinositol[^a^](#t001fn002){ref-type="table-fn"}                                           28.399     217                       85           0.155±0.016        0.263±0.018     0.001   1.258
  29.109   217                                                                                         80                                                                                           
  11       Inositol 1,3,4,5,6-pentakisphosphate[^a^](#t001fn002){ref-type="table-fn"}                  30.537     554                       85           0.197±0.016        0.380±0.047     0.001   1.142
  12       Sucrose[^a^](#t001fn002){ref-type="table-fn"}                                               37.348     361                       94           1.919±0.197        3.285±0.252     0.001   1.285
  13       Malate[^a^](#t001fn002){ref-type="table-fn"}                                                19.653     233                       91           1.585±0.058        0.940±0.082     0.001   1.556
  14       Malonic acid[^a^](#t001fn002){ref-type="table-fn"}                                          12.828     233                       95           0.117±0.014        0.381±0.041     0.001   1.549
  15       Palmitic acid[^a^](#t001fn002){ref-type="table-fn"}[^b^](#t001fn003){ref-type="table-fn"}   29.374     313                       95           0.530±0.023        0.339±0.022     0.001   1.442
  16       Stearic acid[^a^](#t001fn002){ref-type="table-fn"}[^b^](#t001fn003){ref-type="table-fn"}    32.325     341                       99           0.537±0.028        0.327±0.030     0.001   1.321
  17       Acetic acid, hydroxy-[^a^](#t001fn002){ref-type="table-fn"}                                 9.232      205                       92           0.014±0.000        0.012±0.000     0.001   0.901
  18       Pyruvic acid [^a^](#t001fn002){ref-type="table-fn"}                                         9.601      217                       93           0.014±0.001        0.011±0.001     0.001   0.95
  19       Alanine[^a^](#t001fn002){ref-type="table-fn"}[^b^](#t001fn003){ref-type="table-fn"}         10.025     116                       93           0.276±0.013        0.297±0.017     0.163   0.762
  20       Ethanedioic acid[^a^](#t001fn002){ref-type="table-fn"}                                      10.867     190                       94           0.016±0.001        0.018±0.001     0.004   0.834
  21       α-Aminobutyric acid[^a^](#t001fn002){ref-type="table-fn"}                                   11.949     130                       88           0.022±0.002        0.022±0.002     0.907   0.776
  22       Urea[^a^](#t001fn002){ref-type="table-fn"}                                                  12.250     261                       86           0.034±0.002        0.028±0.002     0.038   0.989
  23       beta-Alanine[^a^](#t001fn002){ref-type="table-fn"}                                          12.382     102                       86           0.127±0.013        0.224±0.030     0.001   0.914
  24       Valine[^a^](#t001fn002){ref-type="table-fn"}[^b^](#t001fn003){ref-type="table-fn"}          13.174     144                       89           1.094±0.088        1.057±0.083     0.408   0.820
  25       Benzoic acid[^a^](#t001fn002){ref-type="table-fn"}                                          13.792     179                       80           0.081±0.009        0.120±0.010     0.001   0.986
  26       Phosphate[^a^](#t001fn002){ref-type="table-fn"}                                             14.658     299                       89           0.144±0.018        0.111±0.010     0.024   0.817
  27       Glycerol[^a^](#t001fn002){ref-type="table-fn"}                                              14.724     205                       93           0.327±0.022        0.313±0.014     0.522   0.768
  28       Succinate[^a^](#t001fn002){ref-type="table-fn"}                                             15.495     247                       85           0.995±0.124        0.888±0.060     0.108   0.772
  29       Glyceric acid[^a^](#t001fn002){ref-type="table-fn"}                                         16.068     189                       92           0.057±0.003        0.061±0.003     0.069   0.756
  30       Fumarate[^a^](#t001fn002){ref-type="table-fn"}                                              16.270     245                       83           0.020±0.001        0.022±0.001     0.086   0.735
  31       Pipecolic acid[^a^](#t001fn002){ref-type="table-fn"}                                        16.691     156                       91           0.053±0.009        0.039±0.002     0.076   0.884
  32       Serine[^a^](#t001fn002){ref-type="table-fn"}[^b^](#t001fn003){ref-type="table-fn"}          16.805     204                       91           1.106±0.066        1.122±0.065     0.747   0.723
  33       Threonine[^a^](#t001fn002){ref-type="table-fn"}[^b^](#t001fn003){ref-type="table-fn"}       17.420     218                       95           0.670±0.049        0.670±0.047     1       0.799
  34       2-Piperidone, amino-[^a^](#t001fn002){ref-type="table-fn"}                                  18.833     128                       80           0.045±0.004        0.051±0.004     0.004   0.827
  35       2,2-hydroxymalonate [^a^](#t001fn002){ref-type="table-fn"}                                  19.028     308                       95           0.058±0.003        0.072±0.003     0.001   0.801
  36       Aspartic acid[^a^](#t001fn002){ref-type="table-fn"}[^b^](#t001fn003){ref-type="table-fn"}   20.256     232                       94           0.737±0.130        0.487±0.022     0.022   0.906
  37       Threonic acid[^a^](#t001fn002){ref-type="table-fn"}                                         21.248     292                       95           0.147±0.008        0.169±0.006     0.001   0.946
  38       Threo-2-pentulose[^a^](#t001fn002){ref-type="table-fn"}                                     21.703     306                       80           1.575±0.098        1.369±0.073     0.03    0.864
  39       Ornithine[^a^](#t001fn002){ref-type="table-fn"}[^b^](#t001fn003){ref-type="table-fn"}       22.122     142                       91           0.260±0.032        0.297±0.027     0.112   0.801
  40       Glutamic acid[^a^](#t001fn002){ref-type="table-fn"}[^b^](#t001fn003){ref-type="table-fn"}   22.235     246                       94           0.368±0.017        0.360±0.020     0.742   0.517
  41       Phenylalanine[^a^](#t001fn002){ref-type="table-fn"}[^b^](#t001fn003){ref-type="table-fn"}   22.335     192                       94           0.792±0.070        0.917±0.074     0.018   0.886
  42       Arabitol[^a^](#t001fn002){ref-type="table-fn"}                                              22.938     147                       80           0.108±0.005        0.119±0.004     0.05    0.812
  43       Asparagine[^a^](#t001fn002){ref-type="table-fn"}[^b^](#t001fn003){ref-type="table-fn"}      23.308     231                       95           4.276±0.407        4.110±0.323     0.467   0.799
  44       Arabinose[^a^](#t001fn002){ref-type="table-fn"}                                             23.586     217                       90           0.142±0.007        0.126±0.003     0.004   0.983
  45       α-Aminoadipic acid[^a^](#t001fn002){ref-type="table-fn"}                                    24.027     260                       89           0.052±0.004        0.042±0.003     0.001   0.885
  46       Phosphoric acid, 2,3- hydroxypropyl ester[^a^](#t001fn002){ref-type="table-fn"}             25.049     357                       84           0.063±0.005        0.071±0.004     0.147   0.827
  47       2-keto-1-guconic acid[^a^](#t001fn002){ref-type="table-fn"}                                 25.193     292                       92           0.111±0.005        0.114±0.004     0.526   0.679
  48       Fructofuranose[^a^](#t001fn002){ref-type="table-fn"}                                        25.906     217                       85           0.294±0.035        0.390±0.054     0.033   0.796
  49       Citrate[^a^](#t001fn002){ref-type="table-fn"}                                               26.062     273                       94           0.436±0.030        0.515±0.031     0.05    0.811
  50       Pinitol[^a^](#t001fn002){ref-type="table-fn"}                                               26.412     217                       90           8.838±0.361        8.151±0.154     0.017   0.839
  51       Adenine[^a^](#t001fn002){ref-type="table-fn"}                                               26.701     264                       92           0.077±0.005        0.078±0.004     0.702   0.619
  52       Fructose[^a^](#t001fn002){ref-type="table-fn"}                                              27.098     217                       93           0.524±0.057        0.710±0.070     0.004   0.871
  53       Sorbose[^a^](#t001fn002){ref-type="table-fn"}                                               27.279     217                       89           0.628±0.070        0.899±0.100     0.001   0.895
  54       Galactopyranoside[^a^](#t001fn002){ref-type="table-fn"}                                     27.506     204                       88           1.529±0.106        2.139±0.054     0.002   0.896
  55       Galactose[^a^](#t001fn002){ref-type="table-fn"}                                             27.542     319                       86           0.940±0.120        0.946±0.067     0.001   0.652
  27.765   319                                                                                         90                                                                                           
  56       Histidine[^a^](#t001fn002){ref-type="table-fn"}[^b^](#t001fn003){ref-type="table-fn"}       27.627     254                       84           0.206±0.027        0.262±0.023     0.005   0.874
  57       Ethyl-glucopyranoside[^a^](#t001fn002){ref-type="table-fn"}                                 28.138     204                       84           0.404±0.071        0.497±0.056     0.003   0.725
  58       Glucose[^a^](#t001fn002){ref-type="table-fn"}                                               28.844     204                       93           0.180±0.017        0.291±0.045     0.005   0.881
  31.282   319                                                                                         87                                                                                           
  34.968   204                                                                                         91                                                                                           
  59       Gluconic acid[^a^](#t001fn002){ref-type="table-fn"}                                         29.110     333                       80           0.106±0.005        0.132±0.004     0.001   0.925
  60       Tryptophan[^a^](#t001fn002){ref-type="table-fn"}[^b^](#t001fn003){ref-type="table-fn"}      32.253     202                       93           0.324±0.029        0.343±0.023     0.223   0.763
  61       Lactulose[^a^](#t001fn002){ref-type="table-fn"}                                             33.610     204                       82           0.047±0.002        0.049±0.002     0.472   0.812
  62       Glyceryl-glycoside[^a^](#t001fn002){ref-type="table-fn"}                                    33.813     204                       90           0.175±0.012        0.172±0.004     0.748   0.618
  63       Glucuronic acid[^a^](#t001fn002){ref-type="table-fn"}                                       34.502     204                       80           0.131±0.004        0.124±0.004     0.118   0.834
  64       Uridine[^a^](#t001fn002){ref-type="table-fn"}                                               35.220     217                       90           0.189±0.008        0.164±0.007     0.001   0.829
  65       2-Monopalimitoylglycerol[^a^](#t001fn002){ref-type="table-fn"}                              36.077     129                       88           0.043±0.001        0.041±0.002     0.254   0.719
  66       Monopalmitin[^a^](#t001fn002){ref-type="table-fn"}                                          36.399     371                       81           0.690±0.062        0.951±0.053     0.001   0.968
  67       Turanose[^a^](#t001fn002){ref-type="table-fn"}                                              36.585     361                       82           0.074±0.003        0.082±0.003     0.035   0.917
  68       2-Monostearin[^a^](#t001fn002){ref-type="table-fn"}                                         37.922     129                       80           0.077±0.004        0.077±0.003     0.817   0.578
  69       Monostearin[^a^](#t001fn002){ref-type="table-fn"}                                           38.317     399                       86           0.163±0.006        0.188±0.007     0.003   0.915
  70       Gentiobiose[^a^](#t001fn002){ref-type="table-fn"}                                           39.690     204                       83           0.035±0.002        0.039±0.002     0.063   0.775

RT = retention time of compound.

^a^ Identified by NIST data base.

^b^ Identified by our in-house mass spectra library.

Data from inoculated and control groups was the average of the sum of the normalised data of the compound at each time point, which presented as Mean±SE (n = 3). The data were evaluated by a two-way analysis of variance, through which the *p* value was calculated. The data were determined at 2, 4, 6, 8, 12, 16, 20, 24, 26 and 28 dpi, dpi (day post inoculation). The variable importance values (VIP) were obtained through OPLS-DA analyses.

The R^2^X (cum) value of the PCA model is 0.529, as shown in [Fig 2a](#pone.0206641.g002){ref-type="fig"}. The model could not be used to distinguish between control and pathogen-inoculated groups, however, the OPLS-DA results clearly placed the control and pathogen treatments in two distinct groups. The samples collected from control and pathogen-inoculated groups all fell inside the 95% Hotelling T^2^ ellipse ([Fig 2b](#pone.0206641.g002){ref-type="fig"}). The R^2^Y~(cum)~ and Q^2^ values of this model were 1.000 and 0.817, respectively. Validation plots showed R2 and Q2 values from the permuted analysis (bottom left) are lower than the corresponding original R2 and Q2 values (top right), indicating a good fit for the model ([Fig 2c](#pone.0206641.g002){ref-type="fig"}).

![Multivariate statistical analysis of control samples and infected samples.\
Principal component analysis (PCA) score plot for the inoculated samples (green) and control samples (blue) collected at 2, 4, 6, 8, 12, 16, 20, 24, 26 and 28 days, PC1 is 35.3% and PC2 is 17.2% (a); Orthogonal partial least-squares discriminant analysis (OPLS-DA) score plot (1+4 components), R^2^X~(cum)~ = 0.739, R^2^Y~(cum)~ = 1.000, Q^2^ = 0.817), R^2^X~(cum)~ and R^2^Y~(cum)~ are the cumulative modelled variations in the X and Y matrices, respectively, and Q^2^ value is a prediction error (b); Validation plots of the orthogonal partial least-squares discriminant analysis (POLS-DA) models acquired through 200 permutation tests for the control vs. inoculated groups. T \[1\] = scores for predictive component 1, to \[1\] = scores for orthogonal component 1. The ellipse shows the 95% confidence interval using Hotelling T^2^ statistics. R and Q were obtained after OPLS-DA permutation tests (n = 200), R^2^ intercept was 0.861, Q^2^ intercept was -0.933 (c).](pone.0206641.g002){#pone.0206641.g002}

A total of 16 significantly regulated metabolites (VIP \> 1 and *p* \< 0.05) associated with the pathogen infection were identified using the OPLS-DA model. These metabolites included eight amino acids (glycine, leucine, isoleucine, lysine, tyrosine GABA, 5-oxoproline, and methionine), one nitrogen-containing compound (2-pyrrolidinone), two organic acids (malonic acid and malate), two polyols (myoinositol and inositol 1,3,4,5,6-pentakisphosphate), one sugar (sucrose) and two fatty acids (palmitic acid and stearic acid) ([Fig 3](#pone.0206641.g003){ref-type="fig"}).

![Heat map of significantly regulated metabolites in the alfalfa leaves between control and inoculated groups.\
Metabolite levels in the leaves were shown as log~10~ ratios of values from infected versus uninfected groups at 2, 4, 6, 8, 12, 16, 20, 24, 26 and 28 days post inoculation (dpi). Yellow color shows upregulated compound levels, and the blue color indicates downregulated levels. Level of compounds in the inoculated leaves was significantly lower (SL) or significantly higher (SH) than in the control leaves. Inositol 1,3,4,5,6- is inositol 1,3,4,5,6-pentakisphosphate. Data were evaluated by student's t test and *p*\<0.05 has significant difference.](pone.0206641.g003){#pone.0206641.g003}

Several amino acids, such as glycine, leucine, isoleucine, methionine and tyrosine, and sucrose, myoinositol and inositol 1, 3, 4, 5, 6-pentakisphosphate were downregulated in the *P*. *medicaginis*-inoculated leaves compared to the mock-inoculated leaves after 6 dpi. In contrast, the level of lysine in the *P*. *medicaginis*-inoculated leaves was gradually upregulated 39.1% by 28 dpi.

Some compounds showed a dramatic increase in the *P*. *medicaginis*-inoculated leaves compared with mock-inoculated leaves; for example, the level of 5-oxoproline in the *P*. *medicaginis*-inoculated leaves reached a maximum level of 137.9% by 24 dpi, falling to 74.2% by 28 dpi. Malate dramatically increased by 352.4% at 4 dpi. The levels of palmitic acid and stearic acid reached a maximum level of 266.8% and 291.4%, at 28 dpi, respectively.

Some compounds showed a large decrease in the *P*. *medicaginis-*inoculated leaves compared with the mock-inoculated leaves. The levels of GABA (γ-Aminobutyric acid) and 2-pyrrolidinone decreased over time compared with the control groups, and the levels of malonic acid significantly decreased at early infection stages (*p*\<0.05), but increased by 67.2% at 24 dpi and 38.1% at 28 dpi (t test, *p*\<0.05).

Metabolites related to glycolysis and the TCA cycle were significantly induced at later infection stages (t test, *p*\<0.05). For example, at 28 dpi, pyruvic acid increased 1.69 fold, asparagine increased 1.41 fold, succinate increased 1.90 fold, fumarate increased 1.37 fold, and citrate increased by 2.16 fold compared with the control groups ([Table 2](#pone.0206641.t002){ref-type="table"}).

10.1371/journal.pone.0206641.t002

###### Fold change values from pathogen-inoculated versus control groups at each time points.

![](pone.0206641.t002){#pone.0206641.t002g}

  Metabolite     Fold change                                                                                       
  -------------- ------------- ---------- -------- ---------- -------- ---------- ---------- ---------- ---------- ----------
  Pyruvic acid   1.14          1.45\*     1.36\*   1.20\*\*   1.30     0.59\*     1.48\*     1.46\*     0.97       1.69\*\*
  Asparagine     0.81\*\*      1.26\*\*   0.89     0.93       1.25\*   0.42\*\*   1.46\*\*   1.13       0.84       1.41\*\*
  Succinate      0.77          0.54\*\*   0.80     0.86       1.03     0.39\*\*   1.43\*\*   1.29\*\*   1.41\*\*   1.90\*\*
  Fumarate       0.92          0.62       1.08     0.45       0.94     0.41       1.00       1.33       1.38\*     1.37\*\*
  Citrate        0.77\*\*      0.44\*     0.78     1.40\*\*   0.98     0.22\*\*   1.27\*\*   0.54\*\*   1.20\*\*   2.16\*\*

Fold change is the ratio of data from inoculated versus control groups at 2, 4, 6, 8, 12, 16, 20, 24, 26 and 28 days post inoculation (dpi). Data were evaluated by student's t test and indicated by asterisks (\**p*\<0.05 or \*\**p*\<0.01).

Metabolic pathways {#sec009}
------------------

Of the 16 compounds regulated with infection, 14 compounds were associated with 30 primary metabolic pathways ([S1 Table](#pone.0206641.s001){ref-type="supplementary-material"}). These pathways include metabolism of sugar and alcohol, metabolism of amino acids and organic acids, metabolism of fatty acids and glutathione ([S1 Table](#pone.0206641.s001){ref-type="supplementary-material"}), of which glycolysis, amino acids, inositol phosphate, TCA cycle, fatty acids, and glutathione are most important ([Fig 4](#pone.0206641.g004){ref-type="fig"}). The pathway of 2-pyrrolidinone and malonic acid metabolites were not found to belong to a specific defined metabolic pathway.

![Metabolic pathway network of responsive metabolites in alfalfa leaves infected with *P*. *medicaginis*.\
The black, red, blue, light blue and crimson full and dotted box indicates that metabolites were detected by GC-MS from the alfalfa leaves, and the dotted box presents significant regulated metabolites in the inoculated leaves compared with the controls (VIP\>1.0 and *p*\<0.05). Yellow dotted box indicates that the metabolites were not detected by GC-MS from the alfalfa leaves, but were involved in the corresponding pathway. Green dotted ovals indicates that the metabolic pathway was associated with the regulated metabolites. (VIP, the variable importance for the projection; PEP, phosphoenolpyruvate; TCA cycle, tricarboxylic acid cycle). Red color indicates that the compound was significantly upregulated at later infection stages. Blue color indicates that the compound was significantly downregulated at later infection stages. Light blue color indicates that the compound was significantly downregulated over time. Crimson color indicates that the compound was almost significantly upregulated over time.](pone.0206641.g004){#pone.0206641.g004}

Discussion {#sec010}
==========

During antagonistic interactions between plants and pathogenic fungi, the pathogens try to modulate plant carbon and nitrogen metabolism to ensure their proliferation and survival, while plants need nutrients and energy to synthesize phytoalexins, defense related protein, antioxidants and many other metabolites to resist pathogen infection \[[@pone.0206641.ref026]\].

As disease progressed, lesions enlarged and coalesced, leaves became yellow, and the levels of 16 metabolites in the infected plants were significantly changed compared to the non-infected plants during *P*. *medicaginis* colonization. These metabolites included amino acids (glycine, leucine, isoleucine, tyrosine, lysine, 5-oxoproline, methionine, and GABA), 2-pyrrolidinone and organic acids (malonic acid and malate), sucrose, alcohols (myoinositol and inositol 1,3,4,5,6-pentakisphosphate), and fatty acids (palmitic acid and stearic acid).

The levels of glycine, isoleucine, leucine and tyrosine in the *P*. *medicaginis*-infected alfalfa leaves decreased compared to the uninfected plants. These amino acids are not only the basic units of protein synthesis, but also enhance defense responses to biotic stresses including strengthening of plant cell walls, regulation of jasmonic acid (JA), and biosynthesis of phytoalexins. \[[@pone.0206641.ref027]--[@pone.0206641.ref030]\]. This suggests that the decrease in these amino acids levels in the infected leaves may promote the susceptibility of alfalfa to the pathogen infection.

As shown in [Fig 4](#pone.0206641.g004){ref-type="fig"}, 5-oxoproline and glutathione (GSH) are involved in the glutathione metabolism pathway; 5-oxoproline is a degradation product of glutathione. Upon *P*. *medicaginis* infection, 5-oxoproline levels significantly increased in the inoculated alfalfa leaves in different infection stages, but especially in the later infection (*p*\<0.05). This suggests that the antioxidant system based on the glutathione-mediated detoxification pathway may be induced mostly later in infection. High accumulation of 5-oxoproline may increase plant resistance, and lower levels of the metabolite at early infection stages may help the pathogen colonize the plant. Previous studies showed that antioxidant enzyme activity was induced earlier and to higher levels in the resistant varieties of alfalfa than in the susceptible varieties \[[@pone.0206641.ref013]\]. These results reinforce the expectation that antioxidant compounds and enzymes play a synergistic role in plant disease resistance.

With *P*. *medicaginis* infection, lysine and its degradation product pipecolic acid were induced later and strongly in infected alfalfa leaves, compared with control leaves, which could be related to alfalfa susceptibility. Pipecolic acid was previously shown to induce systemic acquired resistance (SAR) \[[@pone.0206641.ref031]\]. Pipecolic acid was produced faster and higher in *Arabidopsis* leaves inoculated with the incompatible, HR-inducing *Psm avrRpm1* strain than in *Arabidopsis* leaves infected with the compatible *Psm* strain, and pipecolic acid accumulated to higher levels during later stages of the compatible interaction \[[@pone.0206641.ref032]\]. Therefore, later strong induction of lysine degradation in the infected alfalfa leaves may be a way for the pathogen to escape host resistance.

For some pathogens, they need to assimilate methionine or its derivatives from host tissue to support their growth, which is related to their pathogenicity. For instance, methionine auxotrophic mutants of the pathogens *Ustilago maydis* and *Fusairum graminearum*, showed only reduced pathogenicity on plant leaves and were still able to penetrate and colonize host tissues \[[@pone.0206641.ref033],[@pone.0206641.ref034]\]. Under *P*. *medicaginis* infection, methionine levels decreased, which may be related to the assimilation of *P*. *medicaginis*. The pathogen may need to acquire sufficient amounts of methionine from alfalfa leaves to support its growth. Inhibiting the use of methionine by the pathogen can increase alfalfa resistance.

As shown in [S1 Table](#pone.0206641.s001){ref-type="supplementary-material"} and [Fig 4](#pone.0206641.g004){ref-type="fig"}, myoinositol (inositol) and inositol-1, 2, 3, 4, 5, 6-hexakisphosphate are involved in the inositol phosphate metabolism pathway. With *P*. *medicaginis* infection, myoinositol and inositol derivatives (Inositol 1, 3, 4, 5, 6-pentakisphosphate) were induced early but decreased significantly at later infection stages in the infected leaves (*p*\<0.01), which suggested that ability of alfalfa to resist disease decreased. Conversely, early strong induction of myoinositol and inositol derivatives (Inositol 1, 3, 4, 5, 6-pentakisphosphate) may enhance alfalfa resistance. The amounts of myoinositol and inositol derivatives in resistant wheat cultivars (Sumai3) were higher than that in susceptible wheat cultivars (Roblin) \[[@pone.0206641.ref035]\].

In this research, malonic acid decreased in the infected leaves significantly at early infection stages (*p*\<0.05), and accumulated at later infection stages. Malonic acid metabolism likely provides a carbon source for the survival of microorganisms \[[@pone.0206641.ref036],[@pone.0206641.ref037]\]. Therefore, the changes of malonic acid in the alfalfa detected may have provided carbon for *P*. *medicaginis* to invade, increasing host susceptibility.

As shown in [Fig 4](#pone.0206641.g004){ref-type="fig"}, metabolism of sucrose relates to the glycolysis pathway; its end product is pyruvic acid (pyruvate), which was induced significantly at later infection stages (*p*\<0.05) ([Table 2](#pone.0206641.t002){ref-type="table"}). The decrease in sucrose levels may also be involved in promoting the glycolysis pathway in the later infection stages, except when it serves as a carbon source for fungal mycelium growth \[[@pone.0206641.ref005],[@pone.0206641.ref011]\].

In this study, the TCA cycle intermediates malate, fumarate, succinate, and citrate all accumulated significantly in infected leaves at later infection stages (*p*\<0.05) ([Fig 3](#pone.0206641.g003){ref-type="fig"} and [Table 2](#pone.0206641.t002){ref-type="table"}). Moreover, as shown in [Fig 4](#pone.0206641.g004){ref-type="fig"}, GABA and asparagine are synthesized by the TCA cycle, asparagine were induced strongly at late infection stages when compared with controls ([Table 2](#pone.0206641.t002){ref-type="table"}). Asparagine is one of the major metabolic products in senescing leaves \[[@pone.0206641.ref038]\], and it could increase the *P*. *medicaginis* spore germination rate \[[@pone.0206641.ref039]\]. GABA also likely provided an extra source of translocated nitrogen for the growth of the fungus \[[@pone.0206641.ref040]\], 2-Pyrrolidinone (pyrrolidinone) is one important metabolites of GABA \[[@pone.0206641.ref041]\]. These results suggest that impaired photosynthesis of alfalfa leaves caused by the infection of *P*. *mecaginis* may lead to a very strong induction in respiration, TCA cycle and glycolysis in the infected leaves, which could compensate for reduced ATP to the host cells as a result of the impaired photosystem \[[@pone.0206641.ref015]\]. In addition, the decrease in GABA and 2-Pyrrolidinone in the infected leaves may relate to depletion of *P*. *medicaginis*, since these compounds may also provide nitrogen for the pathogen growth and survival. The induction of asparagine through the TCA cycle following *P*. *medicaginis* infection provides a rich nitrogen reservoir to support fungal growth in alfalfa and also facilitate pathogen-initiated host senescence. However, the strong induction of plant respiration by the pathogen may induce senescence leading to host plant death.

Palmitic acid involves fatty acid degradation pathways ([S1 Table](#pone.0206641.s001){ref-type="supplementary-material"} and [Fig 4](#pone.0206641.g004){ref-type="fig"}), the primary manner of fatty acid degradation is β-oxidation, which not only provides a large amount of energy and carbon sources needed for the life activities of plant, but also provides abundant fatty acids and carbon source for pathogen invasion and growth. Under *P*. *medicaginis* infection, genes in the octadecanoid pathway were induced significantly and accumulated more rapidly in a resistant *M*. *truncatula* accession than in a susceptible *M*. *truncatula* accession \[[@pone.0206641.ref030]\]. In our studies, large amounts of palmitic acid (C16) and stearic acid (C18) accumulated in later *P*. *medicaginis* infection stages, suggesting that the induction of β-oxidation in the later infection stages may have provided nutrition for *P*. *medicaginis* for invasion and growth, while the rapid accumulation of these two fatty acids at early infection stages may enhance plant resistance to the pathogen infection.

This research was carried out on a susceptible cultivar. We anticipate that a resistant cultivar would induce intermediate metabolites of glycolysis, TCA cycle and β-oxidation metabolism pathways, and inositol phosphate, glutathione, some amino acids metabolic pathways, such as glycine, leucine, isoleucine, tyrosine and lysine, rapidly and strongly at an early infection stage. When Kamphuis and coworkers compared susceptible and resistant cultivars of *M*. *truncatula* infected by *P*. *medicaginis*, they found expression of genes associated with disease resistance was induced to lower levels in a resistant cultivar later in infection than for a susceptible cultivar. Their experiment showed the greatest upregulation in *PR10* gene expression, lipoxygenase transcripts and isoflavone 2'-hydroxylase in the octadecanoid pathway from resistant plants earlier and to a higher level \[[@pone.0206641.ref030]\]. Our work was done with a different system at the metabolic level, however, we would anticipate that glycine, leucine, isoleucine, tyrosine, lysine, 5-oxoproline, myoinositol and inositol 1,3,4,5,6-pentakisphosphate, palmitic acid and stearic acid would likely be induced early and higher in resistant cultivars. These compounds and their related metabolic pathways could provide information for the identification and characterization of resistant cultivars.

Conclusion {#sec011}
==========

A detailed primary metabolic profile of the response of alfalfa leaves to *P*. *medicaginis* infection was presented. In the process of *P*. *medicaginis* colonization of the alfalfa leaves, glycolysis, TCA cycle and β-oxidation metabolism pathways in the infected leaves accumulated strongly at later infection stages, which may provide ATP, a N source and nutrition for *P*. *medicaginis* to colonize alfalfa leaves. Moreover very strong induction of the TCA cycle pathways by the pathogen at later infection stage may induce senescence in alfalfa leaves, leading to plant death. Intermediates metabolites of these metabolic pathways, and inositol phosphate, glutathione, some amino acids metabolic pathways, such as glycine, leucine, isoleucine, tyrosine and lysine, accumulated rapidly and strongly at an early infection stage may enhance the ability of alfalfa to resist necrotrophic *P*. *medicaginis*. The tentatively identified differential metabolites and related pathways may serve as potential markers for developing novel disease-control strategies and breeding resistant varieties.
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###### Relevant pathways of 16 significant regulated metabolites.

Relevant pathways based on MetaboAnalyst 4.0 analysis.

(DOCX)

###### 

Click here for additional data file.

###### Amount of metabolites in control and inoculated groups at the different times.

Amount of individual metabolite normalised to internal standard is shown.

(XLSX)
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Click here for additional data file.
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